CIDARA Therapeutics COO Ward Sells $2.19 Million in Stock: Implications and Insights
Overview of CIDARA Therapeutics and the Stock Sale CIDARA Therapeutics, founded in 2012, is a biotechnology company focused on developing innovative treatments for infectious diseases. The company leverages its proprietary Cloudbreak® platform to create new therapies designed to treat serious fungal infections and other critical conditions. With a strong commitment to addressing unmet medical needs, […]
CIDARA Therapeutics COO Ward Sells $2.19 Million in Stock: Implications and Insights Read More »